Irish COVID-19 Vasculopathy Study (iCVS)
- Funded by HRB Ireland, Irish Research Council
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$234,862.48Funder
HRB Ireland, Irish Research CouncilPrincipal Investigator
Professor James O'DonnellResearch Location
IrelandLead Research Institution
RCSIResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Our recent work shows blood clotting happens in patients with severe COVID-19 infection leading to more deaths. Patients with higher levels of blood clotting were also more likely to require ICU admission. We want to understand why these micro-clots are being formed in the lungs so that more effective treatments for patients with severe COVID-19 can be developed